Incidence of Cancer Treatment-Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents.

Background The incidence of cancer treatment-induced arrhythmia ( CTIA ) associated with novel, targeted chemotherapeutic agents ( TCA s) has not been well described. Methods and Results We identified all patients treated at our institution from January 2010 to December 2015 with selected TCA s. We defined CTIA as any new arrhythmia diagnosis code within 6 months after treatment initiation.